Missak Haigentz
Chief of Thoracic Medical Oncology and Chief of Head & Neck Medical Oncology, Rutgers Cancer Institute/Jack & Sheryl Morris Cancer Center · Rutgers Health
Credentials: · · · ·
History
- Present
Rutgers Cancer Institute/Jack & Sheryl Morris Cancer Center Division · Rutgers Health
- Present
RWJBarnabas Health · Rutgers Health
- Present
Thoracic/Head & Neck Medical Oncology Division · Rutgers Health
- 1995–1998
- 1991–1995
Research
Adenoid cystic carcinoma of the head and neck--An update
Review · Oral Oncology · 2015 · 420 citations
Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery
Head & Neck · 2012 · 225 citations
Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice
Review · Oral Oncology · 2010 · 181 citations
- CS
27 papers
16 papers
16 papers
16 papers
11 papers
11 papers
10 papers
- GW
9 papers
Grants
- 2026–2032
Clinical Trial Support for the Rutgers Cancer Institute and the RWJBarnabas Health System
National Cancer Institute · UG1
Contact PI · $1.2M · Rutgers Biomedical and Health Sciences
- 2019–2025
The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)
National Cancer Institute · UG1
Contact PI · $1.1M · Atlantic Health System, Inc.
- 2005–2008
Depsipeptide for the Treatment of Head and Neck Cancer
National Cancer Institute · R21
Contact PI · $443.4K · Montefiore Medical Center (Bronx, Ny)
Clinical trials
- 2022–2028
ATATcH Alternating Treatment Plans for Advanced Cancer
Principal investigator · Recruiting · Phase 2
Rutgers, The State University of New Jersey
- 2005–2012
Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2026–2030
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
Site PI · Recruiting · Phase 2
PrECOG, LLC.
- 2020–2026
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)